ReVision Therapeutics, Inc.   Report issue

For profit Phase 2
Founded: San Diego CA United States (2010)
Status: No NME R&D (2010)

Organization Overview

First Clinical Trial
2010
NCT00429936
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Revision Skincare | ReVision Therapeutics Advisor